; (B) by striking 4.6% and inserting 4.9% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (53) Copper phthalocyanine blue crude Heading 9902.08.59 is amended— (A) by amending the article description to read as follows: Copper phthalocyanine ((Phthalocyanato(2-))-copper), not ready for use as pigment (PCN Blue Crude) (CAS No. 147–14–8) (provided for in subheading 3204.17.20) ; (B) by striking 3.3% and inserting 3% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (54) Spirotetramat formulations Heading 9902.09.24 is amended— (A) by amending the article description to read as follows: Product mixtures containing (5s, 8s)-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro [4.5] dec-3-en-4-yl ethyl carbonate (Spirotetramat) (CAS No. 203313–25–1) (provided for in subheading 3808.91.25) ; (B) by striking 5.2% and inserting Free ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (55) Prothioconazole and tebuconazole formulations Heading 9902.09.50 is amended— (A) by amending the article description to read as follows: Product mixtures containing 2-[(2RS)-2-(1-chlorocyclopropyl)-3-(2-chlorophenyl) -2-hydroxypropyl]-2H-1,2,4-triazole-3 (4H)-thione (Prothioconazole) (CAS No. 178928–70–6) and (RS)-1-p-chlorophenyl-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl) pentan-3-ol (Tebuconazole) (CAS No. 107534–96–3) (provided for in subheading 3808.92.15) ; (B) by striking 4.9% and inserting 3.2% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (56) Trifloxystrobin and prothioconazole formulations Heading 9902.09.51 is amended— (A) by amending the article description to read as follows: Product mixtures containing methyl (E)-methoxyimino-{(E)-2-[1-(α,α,α-trifluoro-m-tolyl) ethylideneaminooxy]-o-tolyl}acetate (Trifloxystrobin) (CAS No. 141517–21–7) and 2-[(2RS)-2-(1-chlorocyclopropyl)-3-(2-chlorophenyl) -2-hydroxypropyl]-2H-1,2,4-triazole-3(4H)-thione (Prothioconazole) (CAS No. 178928–70–6) (provided for in subheading 3808.92.15) ; (B) by striking 4.0% and inserting Free